PL433443A1 - Zastosowanie sulfonowanych pochodnych polistyrenu w leczeniu i/lub profilaktyce infekcji wywołanej przez wirus Zika - Google Patents

Zastosowanie sulfonowanych pochodnych polistyrenu w leczeniu i/lub profilaktyce infekcji wywołanej przez wirus Zika

Info

Publication number
PL433443A1
PL433443A1 PL433443A PL43344320A PL433443A1 PL 433443 A1 PL433443 A1 PL 433443A1 PL 433443 A PL433443 A PL 433443A PL 43344320 A PL43344320 A PL 43344320A PL 433443 A1 PL433443 A1 PL 433443A1
Authority
PL
Poland
Prior art keywords
prophylaxis
treatment
zika virus
infection caused
sulfonated polystyrene
Prior art date
Application number
PL433443A
Other languages
English (en)
Other versions
PL241834B1 (pl
Inventor
Krzysztof PYRĆ
Magdalena Obłoza
Maria Nowakowska
Paweł BOTWINA
Krzysztof SZCZUBIAŁKA
Original Assignee
Uniwersytet Jagielloński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagielloński filed Critical Uniwersytet Jagielloński
Priority to PL433443A priority Critical patent/PL241834B1/pl
Priority to EP21722586.1A priority patent/EP4125938B1/en
Priority to PCT/PL2021/000016 priority patent/WO2021201705A1/en
Publication of PL433443A1 publication Critical patent/PL433443A1/pl
Publication of PL241834B1 publication Critical patent/PL241834B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Przedmiotem wynalazku jest sól sodowa poli(4-sulfonianu styrenu) do stosowania w leczeniu i/lub profilaktyce infekcji wywołanej przez wirusa Zika.
PL433443A 2020-04-03 2020-04-03 Zastosowanie sulfonowanych pochodnych polistyrenu w leczeniu i/lub profilaktyce infekcji wywołanej przez wirus Zika PL241834B1 (pl)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL433443A PL241834B1 (pl) 2020-04-03 2020-04-03 Zastosowanie sulfonowanych pochodnych polistyrenu w leczeniu i/lub profilaktyce infekcji wywołanej przez wirus Zika
EP21722586.1A EP4125938B1 (en) 2020-04-03 2021-03-24 Use of sulfonated polystyrene derivatives in the treatment and/or prophylaxis of infection caused by zika virus
PCT/PL2021/000016 WO2021201705A1 (en) 2020-04-03 2021-03-24 Use of sulfonated polystyrene derivatives in the treatment and/or prophylaxis of infection caused by zika virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL433443A PL241834B1 (pl) 2020-04-03 2020-04-03 Zastosowanie sulfonowanych pochodnych polistyrenu w leczeniu i/lub profilaktyce infekcji wywołanej przez wirus Zika

Publications (2)

Publication Number Publication Date
PL433443A1 true PL433443A1 (pl) 2021-10-04
PL241834B1 PL241834B1 (pl) 2022-12-12

Family

ID=75747007

Family Applications (1)

Application Number Title Priority Date Filing Date
PL433443A PL241834B1 (pl) 2020-04-03 2020-04-03 Zastosowanie sulfonowanych pochodnych polistyrenu w leczeniu i/lub profilaktyce infekcji wywołanej przez wirus Zika

Country Status (3)

Country Link
EP (1) EP4125938B1 (pl)
PL (1) PL241834B1 (pl)
WO (1) WO2021201705A1 (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4166146A1 (en) 2021-10-15 2023-04-19 Uniwersytet Jagiellonski Pamps-paau copolymers for use in the treatment or prophylaxis of infection caused by the zika virus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017190193A1 (en) * 2016-05-05 2017-11-09 Starpharma Pty Ltd Method of prophylaxis of zika virus infection

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4166146A1 (en) 2021-10-15 2023-04-19 Uniwersytet Jagiellonski Pamps-paau copolymers for use in the treatment or prophylaxis of infection caused by the zika virus

Also Published As

Publication number Publication date
EP4125938A1 (en) 2023-02-08
WO2021201705A1 (en) 2021-10-07
EP4125938B1 (en) 2024-09-11
PL241834B1 (pl) 2022-12-12

Similar Documents

Publication Publication Date Title
CR20220082A (es) N4-hidroxicitidina y derivados y usos antivirales relacionados con los mismos
BR112022005896A2 (pt) Inibidores da mek para o tratamento de infecções causadas por hantavírus
EA202092003A1 (ru) Соединения для лечения болезни гентингтона
JOP20210301A1 (ar) بيرولات ثلاثية الحلقة مكثفة كمُعدِّلات مضاد تريبسين ألفا-1
MX391226B (es) Inhibidores de transcriptasa inversa de nucleosido 4'-substituido y preparaciones de los mismos.
EA202092899A1 (ru) Гетероарильные соединения для лечения болезни гентингтона
BR112023026976A2 (pt) Inibidores do inflamassoma nlrp3
CL2020001146A1 (es) Nuevas indol-2-carboxamidas sustituidas con pirazolopiperidina, de alta actividad, activas contra el virus de la hepatitis b (vhb).
EA201991556A1 (ru) Ингибиторы фосфодиэстеразы и способы лечения микробной инфекции
BR112018005048B8 (pt) uso de um composto antiviral ou sal do mesmo para o tratamento de uma infecção por coronaviridae
ECSP20029558A (es) Nuevas indol-2-carboxamidas sustituidas con amino-tiazol, de alta actividad, activas contra el virus de la hepatitis b (vhb)
BR112018014794A2 (pt) pirimidinas substituídas com arila para uso em infecção pelo vírus influenza
BR112017004524A2 (pt) pirrolopirimidinas para uso na infecção pelo vírus da gripe
NO20072235L (no) HCV-hemmende bicykliske pyrimidiner
PL433443A1 (pl) Zastosowanie sulfonowanych pochodnych polistyrenu w leczeniu i/lub profilaktyce infekcji wywołanej przez wirus Zika
BR112022001341A2 (pt) Inibidores de enzima
MX2022001933A (es) Inhibidores de enzimas.
MX2022000623A (es) Composiciones y kits para una suspension de omeprazol.
CL2022000214A1 (es) Inhibidores de enzimas
CL2025000338A1 (es) Inhibidores de la proteasa principal de sars-cov2
MX2024009575A (es) Compuestos con estructura en t formada por al menos cuatro ciclos para usar en el tratamiento del cáncer y otras indicaciones.
BR112021018585A2 (pt) Inibidores rsk no tratamento de doenças virais
BR112015023806A2 (pt) Novos regimes de dosagem de celgosivir para o tratamento de dengue
MX2024014373A (es) Inhibidores de flavivirus
EA202090719A1 (ru) Модифицированные нуклеозидные амидофосфиты